Pfizer, Ranbaxy Deal Would Delay Generic Lipitor

June 17, 2008

Pfizer Inc. said on Wednesday that Ranbaxy Laboratories Ltd. can begin selling a U.S. generic form of its Lipitor cholesterol fighter by late 2011 under a settlement deal, some five months later than Wall Street expectations.

*For more on this story,

read the full Reuters article. >>

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Weekly in-depth coverage in print and digital formats
Special Features: OC's Wealthiest, Top Priced Home Sales, Giving Guide, OC500, Charity Event Guide, Best Places to Work, Indispensables, Largest Charitable Gifts
The annual Book of Lists: Orange County's top companies across every industry

Bush Urges Congress Lift Ban On Offshore Drilling

Fuel Spike Curbs Vacations, Dining Out: Poll

staff-author

Pfizer, Ranbaxy Deal Would Delay Generic Lipitor

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Photos: The Emerald Bay Home That Sold for a Record $110M

Inside KIngsbarn Realty Capital and Kelemen’s Terravita Project in Laguna Hills

OC Unemployment Falls to 3.5% in May

Related Articles

Photos: The Emerald Bay Home That Sold for a Record $110M

Inside KIngsbarn Realty Capital and Kelemen’s Terravita Project in Laguna Hills

OC Unemployment Falls to 3.5% in May

Midday Stock Roundup: Indie Semiconductor Shares Jump 8%, Trading at Double its Usual Volume

‘Wide-lot’ Estate in Corona del Mar Sells for $17.7M

Advertise With Us

About Us

Subscriber Links

Other Journals